Skip to content

Advocatetanmoy Law Library

Legal Database

United States Code

  • Title 1. General Provisions
  • Title 2. The Congress
  • Title 3. The President
  • Title 4. Flag and Seal, Seat of Government, and the States
  • Title 5. Government Organization and Employees
  • Title 6. Domestic Security
  • Title 7. Agriculture
  • Title 8. Aliens and Nationality
  • Title 9. Arbitration
  • Title 10. Armed Forces
  • Title 11. Bankruptcy
  • Title 12. Banks and Banking
  • Title 13. Census
  • Title 14. Coast Guard
  • Title 15. Commerce and Trade
  • Title 16. Conservation
  • Title 17. Copyrights
  • Title 18. Crimes and Criminal Procedure
  • Title 19. Customs Duties
  • Title 20. Education
  • Title 21. Food and Drugs
  • Title 22. Foreign Relations and Intercourse
  • Title 23. Highways
  • Title 24. Hospitals and Asylums
  • Title 25. Indians
  • Title 26. Internal Revenue Code
  • Title 27. Intoxicating Liquors
  • Title 28. Judiciary and Judicial Procedure
  • Title 29. Labor
  • Title 30. Mineral Lands and Mining
  • Title 31. Money and Finance
  • Title 32. National Guard
  • Title 33. Navigation and Navigable Waters
  • Title 35. Patents
  • Title 36. Patriotic and National Observances, Ceremonies, and Organizations
  • Title 37. Pay and Allowances of the Uniformed Services
  • Title 38. Veterans' Benefits
  • Title 39. Postal Service
  • Title 40. Public Buildings, Property, and Works
  • Title 41. Public Contracts
  • Title 42. The Public Health and Welfare
  • Title 43. Public Lands
  • Title 44. Public Printing and Documents
  • Title 45. Railroads
  • Title 46. Shipping
  • Title 47. Telecommunications
  • Title 48. Territories and Insular Possessions
  • Title 49. Transportation
  • Title 50. War and National Defense
  • Title 51. National and Commercial Space Programs
  • Title 52. Voting and Elections
  • Title 54. National Park Service and Related Programs

Read More

  • Home
    • About
  • UPDATES
  • Courts
  • Constitutions
  • Law Exam
  • Pleading
  • Indian Law
  • Notifications
  • Glossary
  • Account
  • Home
  • 2021
  • April
  • 15
  • After reports of rare blood clotting,the US,EU and South Africa have paused the roll out of Jonhson and Johnson’s coronavirus vaccine
  • Health Services

After reports of rare blood clotting,the US,EU and South Africa have paused the roll out of Jonhson and Johnson’s coronavirus vaccine

Scientists in Norway and Germany first raised the possibility that some people are experiencing an abnormal immune system response to the AstraZeneca vaccine, forming antibodies that attack their own platelets. That's the theory as the US now investigates clots in J&J vaccine recipients, Dr. Peter Marks, the Food and Drug Administration's vaccine chief, said Tuesday, AP reported.
3 min read
Print Friendly, PDF & Email

DATE: 16TH APRIL 2021

Recommendation to Pause Use of Johnson & Johnson’s Janssen COVID-19 Vaccine in US

On April 13, 2021, CDC and FDA recommended a pause in the use of Johnson & Johnson’s Janssen COVID-19 Vaccine. Of the nearly 7 million doses administered so far in the United States, a small number of cases of a rare and severe type of blood clot have been reported in people after receiving the J&J/Janssen COVID-19 Vaccine. All reports occurred among women between the ages of 18 and 48, and symptoms occurred six to 13 days after vaccination. As of April 13, 2021, no cases have been reported among the more than 180 million people who received the Pfizer-BioNTech or Moderna vaccines.

The use of Janssen COVID-19 Vaccine is ‘paused’ for now. This is because the safety systems that make sure vaccines are safe received a small number of reports of a rare and severe type of blood clot happening in people who got this vaccine.

We do not know enough yet to say if the vaccine is related to or caused this health issue. To be extra careful, CDC and FDA recommend that the vaccine not be given until we learn more.

CDC and FDA recommended this pause to communicate with and prepare the healthcare system to recognize and treat patients appropriately. Communication with healthcare providers will also emphasize the importance of reporting and how to report severe events in people who have received this vaccine. This pause also will allow CDC’s independent advisory committee, the Advisory Committee on Immunization Practices, to meet, review these cases, and assess their potential significance.

What to Do If You Received the J&J/Janssen COVID-19 Vaccine

If you received the vaccine more than three weeks ago, the risk of developing a blood clot is likely  low at this time.

If you received the vaccine within the last three weeks, your risk of developing a blood clot is also  low and that risk will decrease over time.

Contact your healthcare provider and seek medical treatment urgently if you develop any of the following symptoms:

  • severe headache,
  • backache,
  • new neurologic symptoms,
  • severe abdominal pain,
  • shortness of breath,
  • leg swelling,
  • tiny red spots on the skin (petechiae), or
  • new or easy bruising

If you are scheduled to get the J&J/Janssen COVID-19 Vaccine, please work with your vaccine provider to reschedule your appointment to receive another authorized and recommended COVID-19 vaccine. There are two other COVID-19 vaccines authorized and recommended for use in the United States: Pfizer-BioNTech and Moderna.

Graphic-Vector-virus-vaccines

 

Symptoms of Covid-19

We should remember that people with COVID-19 have had a wide range of symptoms reported – ranging from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms may have COVID-19:

  • Fever or chills
  • Cough
  • Shortness of breath or difficulty breathing
  • Fatigue
  • Muscle or body aches
  • Headache
  • New loss of taste or smell
  • Sore throat
  • Congestion or runny nose
  • Nausea or vomiting
  • Diarrhea

All the above said symptoms are common in case of ‘flu’ or Influenza

Photo Courtesy- Gulf News


Read also

Seasonal influenza causes sudden fever, dry cough, headache, muscle-joint pain, sore throat and runny nose.

Flu and Influenza immunisation in UK-29,000 citizens died in 1989/90

Related

Tags: Corona Virus featured Health care Vaccines

Continue Reading

Previous: DCGI approved Russian Sputnik-V vaccine for immunization to prevent COVID-19 disease
Next: Oxygen Toxicity- Clinical application of Oxygen, its effective and toxic doses

Indian Supreme Court Digest

  • ISKCON leaders, engage themselves into frivolous litigations and use court proceedings as a platform to settle their personal scores-(SC-18/05/2023)
  • High Court would not interfere by a Revision against a decree or order u/s 6 of SRA if there is no exceptional case (SC-2/4/2004)
  • Borrower may file a counterclaim either before DRT in a proceeding filed by Bank under RDB Act or a Civil Suit under CPC-SC (10/11/2022)
  • When Supreme Court interfered in case of High Court refused Anticipatory Bail (02/12/2022)
  • Award can be modified only to the extent of arithmetical or clerical error-SC (22/11/2021)

Write A Guest Post

Current Posts

PM’s address at the celebration of dedication of New Parliament Building to the Nation (28/05/2023)
1 min read
  • Speeches

PM’s address at the celebration of dedication of New Parliament Building to the Nation (28/05/2023)

Betrayal In India-D F KARAKA (1950)
329 min read
  • BOOK

Betrayal In India-D F KARAKA (1950)

Siva’s 1000 Names (शिवसहस्रनामावलिः)
1 min read
  • Sanskrit Documents

Siva’s 1000 Names (शिवसहस्रनामावलिः)

History of the Banaras Hindu University by S L Dar (2007)
4 min read
  • BOOK

History of the Banaras Hindu University by S L Dar (2007)

  • DATABASE
  • INDEX
  • JUDGMENTS
  • CONTACT US
  • DISCLAIMERS
  • RSS
  • PRIVACY
  • ACCOUNT
Copyright by Advocatetanmoy.
 

Loading Comments...
 

You must be logged in to post a comment.